MELPHALAN

Basic Information

Item Value
DrugBank ID DB01042
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 22

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 primary non-gestational choriocarcinoma of ovary TxGNN Knowledge Graph
2 malignant sex cord stromal tumor of ovary TxGNN Knowledge Graph
3 malignant non-dysgerminomatous germ cell tumor of ovary TxGNN Knowledge Graph
4 ovarian cancer TxGNN Knowledge Graph
5 ovarian clear cell adenocarcinoma TxGNN Knowledge Graph
6 ovarian mucinous adenocarcinoma TxGNN Knowledge Graph
7 immature ovarian teratoma TxGNN Knowledge Graph
8 hereditary site-specific ovarian cancer syndrome TxGNN Knowledge Graph
9 plasma cell myeloma TxGNN Knowledge Graph
10 ovarian adenocarcinoma TxGNN Knowledge Graph
11 ovarian small cell carcinoma TxGNN Knowledge Graph
12 theca steroid-producing cell malignant tumor of ovary, not further specified TxGNN Knowledge Graph
13 hereditary breast ovarian cancer syndrome TxGNN Knowledge Graph
14 borderline epithelial tumor of ovary TxGNN Knowledge Graph
15 maligant granulosa cell tumor of ovary TxGNN Knowledge Graph
16 malignant dysgerminomatous germ cell tumor of ovary TxGNN Knowledge Graph
17 familial ovarian cancer TxGNN Knowledge Graph
18 ovarian endometrioid adenocarcinoma TxGNN Knowledge Graph
19 ovarian carcinosarcoma TxGNN Knowledge Graph
20 yolk sac tumor TxGNN Knowledge Graph
21 malignant germ cell tumor of ovary TxGNN Knowledge Graph
22 malignant Sertoli-Leydig cell tumor of ovary TxGNN Knowledge Graph

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search